US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 94.150
  • -2.470-2.56%
Close Nov 22 16:00 ET
  • 94.150
  • 0.0000.00%
Post 16:20 ET
5.98BMarket Cap-45047P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
2.97%734.17M
5.67%763.6M
-21.20%647.9M
-24.80%710.64M
-24.80%710.64M
-37.29%712.98M
-15.29%722.63M
40.10%822.16M
98.06%944.99M
98.06%944.99M
-Cash and cash equivalents
59.64%89.36M
-27.48%54.77M
-33.23%113.33M
-40.45%71.29M
-40.45%71.29M
-80.79%55.97M
-56.44%75.53M
356.26%169.72M
-42.98%119.71M
-42.98%119.71M
-Short-term investments
-1.86%644.82M
9.54%708.83M
-18.06%534.58M
-22.53%639.36M
-22.53%639.36M
-22.30%657.01M
-4.80%647.11M
18.71%652.44M
208.90%825.28M
208.90%825.28M
Receivables
59.53%65.81M
122.28%85.06M
91.83%60.05M
16.89%43.18M
16.89%43.18M
88.25%41.25M
30.12%38.27M
-3.97%31.3M
-0.25%36.94M
-0.25%36.94M
-Accounts receivable
61.07%65.81M
142.01%85.06M
100.11%60.05M
82.05%42.83M
82.05%42.83M
111.50%40.86M
29.58%35.15M
4.34%30.01M
-6.48%23.53M
-6.48%23.53M
-Other receivables
----
----
----
-97.38%351K
-97.38%351K
-84.86%393K
36.42%3.12M
-66.25%1.3M
12.95%13.41M
12.95%13.41M
Inventory
-23.87%12.53M
-13.09%14.79M
76.59%30.94M
-28.53%21.22M
-28.53%21.22M
-53.32%16.46M
-52.01%17.02M
-41.88%17.52M
36.12%29.7M
36.12%29.7M
Other current assets
12.96%42.33M
19.98%40.1M
28.46%37.71M
-4.78%33.35M
-4.78%33.35M
11.76%37.48M
-2.30%33.42M
-22.07%29.36M
93.89%35.02M
93.89%35.02M
Total current assets
5.78%854.85M
11.37%903.54M
-13.74%776.6M
-22.76%808.39M
-22.76%808.39M
-34.17%808.17M
-14.79%811.34M
31.01%900.34M
88.92%1.05B
88.92%1.05B
Non current assets
Net PPE
-9.99%104.27M
-4.75%109.05M
-0.21%113.17M
0.39%115.65M
0.39%115.65M
-1.30%115.84M
-3.81%114.49M
-4.88%113.41M
-4.69%115.2M
-4.69%115.2M
-Gross PPE
-9.99%104.27M
-4.75%109.05M
-0.21%113.17M
5.23%154.14M
5.23%154.14M
-1.30%115.84M
-3.81%114.49M
-4.88%113.41M
0.14%146.48M
0.14%146.48M
-Accumulated depreciation
----
----
----
-23.05%-38.49M
-23.05%-38.49M
----
----
----
-23.07%-31.28M
-23.07%-31.28M
Investments and advances
24.54%176.88M
-6.39%132.66M
-30.82%115.49M
-47.72%84.32M
-47.72%84.32M
70.17%142.03M
50.69%141.72M
-45.54%166.94M
-71.07%161.27M
-71.07%161.27M
Other non current assets
62.16%63.66M
49.89%58.31M
-16.30%33.21M
52.66%40.89M
52.66%40.89M
31.33%39.26M
43.03%38.9M
30.91%39.68M
35.21%26.78M
35.21%26.78M
Total non current assets
16.04%344.8M
1.66%300.02M
-18.17%261.87M
-20.58%240.86M
-20.58%240.86M
28.78%297.13M
22.83%295.11M
-29.83%320.03M
-56.57%303.25M
-56.57%303.25M
Total assets
8.54%1.2B
8.78%1.2B
-14.90%1.04B
-22.27%1.05B
-22.27%1.05B
-24.21%1.11B
-7.21%1.11B
6.74%1.22B
7.80%1.35B
7.80%1.35B
Liabilities
Current liabilities
Payables
-32.27%4.72M
-30.39%4.86M
-53.37%4.93M
72.59%4.71M
72.59%4.71M
64.49%6.96M
-53.64%6.98M
-41.19%10.56M
-67.25%2.73M
-67.25%2.73M
-accounts payable
-32.27%4.72M
-30.39%4.86M
-53.37%4.93M
72.59%4.71M
72.59%4.71M
64.49%6.96M
-53.64%6.98M
-41.19%10.56M
-67.25%2.73M
-67.25%2.73M
Current accrued expenses
-0.64%59.44M
7.53%66.05M
-16.54%66.51M
-26.54%67.09M
-26.54%67.09M
-32.68%59.82M
-34.07%61.43M
-2.81%79.69M
2.93%91.33M
2.93%91.33M
Current provisions
93.63%31.18M
79.09%24.28M
72.55%20.76M
93.07%17.47M
93.07%17.47M
152.37%16.1M
120.37%13.56M
136.22%12.03M
130.41%9.05M
130.41%9.05M
Current debt and capital lease obligation
38.73%58.04M
108.98%60.92M
50.06%42.42M
53.89%42.21M
53.89%42.21M
64.68%41.84M
208.95%29.15M
222.63%28.27M
238.93%27.43M
238.93%27.43M
-Current debt
49.01%45.03M
170.25%48.26M
73.63%30.18M
79.68%30.28M
79.68%30.28M
97.65%30.22M
--17.86M
--17.38M
--16.85M
--16.85M
-Current capital lease obligation
12.00%13.01M
12.10%12.66M
12.43%12.24M
12.80%11.93M
12.80%11.93M
14.84%11.62M
19.68%11.29M
24.25%10.89M
30.72%10.58M
30.72%10.58M
Current deferred liabilities
67.83%64.02M
81.14%57.49M
106.95%51.98M
82.26%40.01M
82.26%40.01M
51.93%38.15M
111.73%31.74M
161.53%25.12M
90.72%21.95M
90.72%21.95M
Current liabilities
30.54%257.66M
44.24%243.8M
19.64%206.6M
17.29%214.92M
17.29%214.92M
12.46%197.38M
6.47%169.03M
26.02%172.68M
22.35%183.23M
22.35%183.23M
Non current liabilities
Long term debt and capital lease obligation
41.50%413.45M
97.85%413.9M
35.66%287.69M
35.00%290.29M
35.00%290.29M
33.69%292.19M
113.12%209.2M
110.47%212.07M
108.12%215.02M
108.12%215.02M
-Long term debt
64.08%341.54M
177.25%338.66M
71.30%209.21M
70.61%208.54M
70.61%208.54M
69.15%208.16M
--122.15M
--122.13M
--122.23M
--122.23M
-Long term capital lease obligation
-14.42%71.92M
-13.56%75.24M
-12.73%78.49M
-11.90%81.75M
-11.90%81.75M
-12.00%84.04M
-11.32%87.05M
-10.74%89.94M
-10.19%92.79M
-10.19%92.79M
Non current deferred liabilities
-48.97%209.22M
-46.89%219.83M
-45.55%227.73M
-4.56%407.22M
-4.56%407.22M
-1.24%410.01M
132.02%413.93M
2,948.00%418.22M
1,602.18%426.67M
1,602.18%426.67M
Other non current liabilities
98.87%6.17M
82.98%5.78M
85.88%5.77M
-39.69%6.21M
-39.69%6.21M
-64.96%3.1M
-66.28%3.16M
-69.39%3.1M
208.04%10.3M
208.04%10.3M
Total non current liabilities
-10.84%628.84M
2.11%639.52M
-17.71%521.19M
7.93%703.72M
7.93%703.72M
9.76%705.3M
119.03%626.29M
408.27%633.39M
394.96%651.99M
394.96%651.99M
Total liabilities
-1.79%886.5M
11.07%883.32M
-9.71%727.79M
9.99%918.64M
9.99%918.64M
10.34%902.69M
78.84%795.32M
208.08%806.07M
196.72%835.23M
196.72%835.23M
Shareholders'equity
Share capital
3.28%63K
3.28%63K
5.00%63K
1.67%61K
1.67%61K
1.67%61K
1.67%61K
0.00%60K
1.69%60K
1.69%60K
-common stock
3.28%63K
3.28%63K
5.00%63K
1.67%61K
1.67%61K
1.67%61K
1.67%61K
0.00%60K
1.69%60K
1.69%60K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-5.74%-2.36B
-9.81%-2.3B
-14.69%-2.25B
-27.66%-2.34B
-27.66%-2.34B
-33.13%-2.23B
-35.96%-2.1B
-42.06%-1.96B
-43.71%-1.83B
-43.71%-1.83B
Paid-in capital
9.73%2.67B
8.89%2.62B
7.72%2.57B
4.92%2.47B
4.92%2.47B
4.50%2.43B
4.67%2.41B
4.67%2.38B
4.79%2.36B
4.79%2.36B
Gains losses not affecting retained earnings
60.12%-1.07M
7.84%-3.89M
16.41%-3.85M
66.53%-3.5M
66.53%-3.5M
81.90%-2.68M
70.37%-4.22M
62.00%-4.6M
-152.67%-10.44M
-152.67%-10.44M
Total stockholders'equity
54.56%313.15M
2.93%320.24M
-25.01%310.69M
-74.62%130.61M
-74.62%130.61M
-68.36%202.61M
-58.39%311.13M
-53.01%414.3M
-46.98%514.68M
-46.98%514.68M
Total equity
54.56%313.15M
2.93%320.24M
-25.01%310.69M
-74.62%130.61M
-74.62%130.61M
-68.36%202.61M
-58.39%311.13M
-53.01%414.3M
-46.98%514.68M
-46.98%514.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 2.97%734.17M5.67%763.6M-21.20%647.9M-24.80%710.64M-24.80%710.64M-37.29%712.98M-15.29%722.63M40.10%822.16M98.06%944.99M98.06%944.99M
-Cash and cash equivalents 59.64%89.36M-27.48%54.77M-33.23%113.33M-40.45%71.29M-40.45%71.29M-80.79%55.97M-56.44%75.53M356.26%169.72M-42.98%119.71M-42.98%119.71M
-Short-term investments -1.86%644.82M9.54%708.83M-18.06%534.58M-22.53%639.36M-22.53%639.36M-22.30%657.01M-4.80%647.11M18.71%652.44M208.90%825.28M208.90%825.28M
Receivables 59.53%65.81M122.28%85.06M91.83%60.05M16.89%43.18M16.89%43.18M88.25%41.25M30.12%38.27M-3.97%31.3M-0.25%36.94M-0.25%36.94M
-Accounts receivable 61.07%65.81M142.01%85.06M100.11%60.05M82.05%42.83M82.05%42.83M111.50%40.86M29.58%35.15M4.34%30.01M-6.48%23.53M-6.48%23.53M
-Other receivables -------------97.38%351K-97.38%351K-84.86%393K36.42%3.12M-66.25%1.3M12.95%13.41M12.95%13.41M
Inventory -23.87%12.53M-13.09%14.79M76.59%30.94M-28.53%21.22M-28.53%21.22M-53.32%16.46M-52.01%17.02M-41.88%17.52M36.12%29.7M36.12%29.7M
Other current assets 12.96%42.33M19.98%40.1M28.46%37.71M-4.78%33.35M-4.78%33.35M11.76%37.48M-2.30%33.42M-22.07%29.36M93.89%35.02M93.89%35.02M
Total current assets 5.78%854.85M11.37%903.54M-13.74%776.6M-22.76%808.39M-22.76%808.39M-34.17%808.17M-14.79%811.34M31.01%900.34M88.92%1.05B88.92%1.05B
Non current assets
Net PPE -9.99%104.27M-4.75%109.05M-0.21%113.17M0.39%115.65M0.39%115.65M-1.30%115.84M-3.81%114.49M-4.88%113.41M-4.69%115.2M-4.69%115.2M
-Gross PPE -9.99%104.27M-4.75%109.05M-0.21%113.17M5.23%154.14M5.23%154.14M-1.30%115.84M-3.81%114.49M-4.88%113.41M0.14%146.48M0.14%146.48M
-Accumulated depreciation -------------23.05%-38.49M-23.05%-38.49M-------------23.07%-31.28M-23.07%-31.28M
Investments and advances 24.54%176.88M-6.39%132.66M-30.82%115.49M-47.72%84.32M-47.72%84.32M70.17%142.03M50.69%141.72M-45.54%166.94M-71.07%161.27M-71.07%161.27M
Other non current assets 62.16%63.66M49.89%58.31M-16.30%33.21M52.66%40.89M52.66%40.89M31.33%39.26M43.03%38.9M30.91%39.68M35.21%26.78M35.21%26.78M
Total non current assets 16.04%344.8M1.66%300.02M-18.17%261.87M-20.58%240.86M-20.58%240.86M28.78%297.13M22.83%295.11M-29.83%320.03M-56.57%303.25M-56.57%303.25M
Total assets 8.54%1.2B8.78%1.2B-14.90%1.04B-22.27%1.05B-22.27%1.05B-24.21%1.11B-7.21%1.11B6.74%1.22B7.80%1.35B7.80%1.35B
Liabilities
Current liabilities
Payables -32.27%4.72M-30.39%4.86M-53.37%4.93M72.59%4.71M72.59%4.71M64.49%6.96M-53.64%6.98M-41.19%10.56M-67.25%2.73M-67.25%2.73M
-accounts payable -32.27%4.72M-30.39%4.86M-53.37%4.93M72.59%4.71M72.59%4.71M64.49%6.96M-53.64%6.98M-41.19%10.56M-67.25%2.73M-67.25%2.73M
Current accrued expenses -0.64%59.44M7.53%66.05M-16.54%66.51M-26.54%67.09M-26.54%67.09M-32.68%59.82M-34.07%61.43M-2.81%79.69M2.93%91.33M2.93%91.33M
Current provisions 93.63%31.18M79.09%24.28M72.55%20.76M93.07%17.47M93.07%17.47M152.37%16.1M120.37%13.56M136.22%12.03M130.41%9.05M130.41%9.05M
Current debt and capital lease obligation 38.73%58.04M108.98%60.92M50.06%42.42M53.89%42.21M53.89%42.21M64.68%41.84M208.95%29.15M222.63%28.27M238.93%27.43M238.93%27.43M
-Current debt 49.01%45.03M170.25%48.26M73.63%30.18M79.68%30.28M79.68%30.28M97.65%30.22M--17.86M--17.38M--16.85M--16.85M
-Current capital lease obligation 12.00%13.01M12.10%12.66M12.43%12.24M12.80%11.93M12.80%11.93M14.84%11.62M19.68%11.29M24.25%10.89M30.72%10.58M30.72%10.58M
Current deferred liabilities 67.83%64.02M81.14%57.49M106.95%51.98M82.26%40.01M82.26%40.01M51.93%38.15M111.73%31.74M161.53%25.12M90.72%21.95M90.72%21.95M
Current liabilities 30.54%257.66M44.24%243.8M19.64%206.6M17.29%214.92M17.29%214.92M12.46%197.38M6.47%169.03M26.02%172.68M22.35%183.23M22.35%183.23M
Non current liabilities
Long term debt and capital lease obligation 41.50%413.45M97.85%413.9M35.66%287.69M35.00%290.29M35.00%290.29M33.69%292.19M113.12%209.2M110.47%212.07M108.12%215.02M108.12%215.02M
-Long term debt 64.08%341.54M177.25%338.66M71.30%209.21M70.61%208.54M70.61%208.54M69.15%208.16M--122.15M--122.13M--122.23M--122.23M
-Long term capital lease obligation -14.42%71.92M-13.56%75.24M-12.73%78.49M-11.90%81.75M-11.90%81.75M-12.00%84.04M-11.32%87.05M-10.74%89.94M-10.19%92.79M-10.19%92.79M
Non current deferred liabilities -48.97%209.22M-46.89%219.83M-45.55%227.73M-4.56%407.22M-4.56%407.22M-1.24%410.01M132.02%413.93M2,948.00%418.22M1,602.18%426.67M1,602.18%426.67M
Other non current liabilities 98.87%6.17M82.98%5.78M85.88%5.77M-39.69%6.21M-39.69%6.21M-64.96%3.1M-66.28%3.16M-69.39%3.1M208.04%10.3M208.04%10.3M
Total non current liabilities -10.84%628.84M2.11%639.52M-17.71%521.19M7.93%703.72M7.93%703.72M9.76%705.3M119.03%626.29M408.27%633.39M394.96%651.99M394.96%651.99M
Total liabilities -1.79%886.5M11.07%883.32M-9.71%727.79M9.99%918.64M9.99%918.64M10.34%902.69M78.84%795.32M208.08%806.07M196.72%835.23M196.72%835.23M
Shareholders'equity
Share capital 3.28%63K3.28%63K5.00%63K1.67%61K1.67%61K1.67%61K1.67%61K0.00%60K1.69%60K1.69%60K
-common stock 3.28%63K3.28%63K5.00%63K1.67%61K1.67%61K1.67%61K1.67%61K0.00%60K1.69%60K1.69%60K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -5.74%-2.36B-9.81%-2.3B-14.69%-2.25B-27.66%-2.34B-27.66%-2.34B-33.13%-2.23B-35.96%-2.1B-42.06%-1.96B-43.71%-1.83B-43.71%-1.83B
Paid-in capital 9.73%2.67B8.89%2.62B7.72%2.57B4.92%2.47B4.92%2.47B4.50%2.43B4.67%2.41B4.67%2.38B4.79%2.36B4.79%2.36B
Gains losses not affecting retained earnings 60.12%-1.07M7.84%-3.89M16.41%-3.85M66.53%-3.5M66.53%-3.5M81.90%-2.68M70.37%-4.22M62.00%-4.6M-152.67%-10.44M-152.67%-10.44M
Total stockholders'equity 54.56%313.15M2.93%320.24M-25.01%310.69M-74.62%130.61M-74.62%130.61M-68.36%202.61M-58.39%311.13M-53.01%414.3M-46.98%514.68M-46.98%514.68M
Total equity 54.56%313.15M2.93%320.24M-25.01%310.69M-74.62%130.61M-74.62%130.61M-68.36%202.61M-58.39%311.13M-53.01%414.3M-46.98%514.68M-46.98%514.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+0.43%